Loading organizations...
§ Private Profile · San Francisco, CA, USA
Develops voice AI agents using large language models to automate healthcare calls like benefit verifications and prior authorizations.
Infinitus Systems develops voice AI agents and copilots utilizing safe large language models to automate routine healthcare calls, such as benefit verifications and prior authorizations. Their digital assistant, Eva, handles interactions between pharmacies, providers, and payors, having automated over 100 million minutes of conversation across more than 6 million calls. The company serves a broad client base, including Fortune 50 companies and 8 out of 10 top pharmaceutical manufacturers, supporting over 120,000 providers. Backed by investors like Andreessen Horowitz, Infinitus Systems has achieved a valuation exceeding $600 million. This technology aims to address healthcare workforce shortages by automating clinical and administrative workflows. Infinitus Systems was founded in 2020 by Ankit Jain and Shyam Rajagopalan. Its business model centers on saaS model serving healthcare organizations, automating calls for leading brands and pharmaceutical manufacturers.
Infinitus Systems has raised $103.0M across 3 funding rounds.
Infinitus Systems has raised $103.0M in total across 3 funding rounds.
Infinitus Systems has raised $103.0M across 3 funding rounds. Most recently, it raised $52.0M Series C in October 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 1, 2024 | $52M Series C | — | Andreessen Horowitz, ARCH Venture Partners, Atlas Venture, Krishna Yeshwant, GV, Pfizer Venture Investments, Quiet Capital, RA Capital, SR ONE, Bill Gates, Diego Oppenheimer, Gokul Rajaram, YAN David Erlich | Announced |
| Nov 1, 2021 | $30M Series B | GV | ARCH Venture Partners, Atlas Venture, Pfizer Venture Investments, RA Capital, SR ONE, Bill Gates | Announced |
| Feb 1, 2021 | $21M Series A | Coatue | Arthur Ventures, First Round Capital, Javelin Venture Partners, Uncork Capital, Western Technology Investment | Announced |
Infinitus Systems has raised $103.0M in total across 3 funding rounds.
Infinitus Systems's investors include Andreessen Horowitz, ARCH Venture Partners, Atlas Venture, Krishna Yeshwant, GV, Pfizer Venture Investments, Quiet Capital, RA Capital, SR One, Bill Gates, Diego Oppenheimer, Gokul Rajaram.
Infinitus Systems is a healthcare-focused AI company that builds voice AI agents to automate routine phone calls between providers, payors, pharmacies and patients, reducing manual work and hold times for administrative healthcare tasks.[5][4]
High-Level Overview
Infinitus Systems is a Voice AI platform provider that automates clinical and administrative healthcare phone calls (benefits verification, prior authorization, pharmacy calls, etc.) using autonomous AI agents such as its digital assistant Eva to offload repetitive call volume for health systems, specialty pharmacies, payors and biopharma programs[5][1].[2] The product is positioned to save organizations time and money (Infinitus reports typical ROIs near 50% and measurable increases in data accuracy) while improving patient and staff experience by reducing hold times and manual workflows[5][2].[5]
Origin Story
Infinitus was founded in 2019 and is headquartered in San Francisco, with co‑founders including Ankit Jain (CEO) and Shyam Rajagopalan (CTO); Jain previously led engineering at Google and Rajagopalan worked in security at Snap, per early company profiles and coverage when the company emerged from stealth with initial funding in 2021[1].[1] The idea grew from addressing persistent, high‑volume phone-based workflows in U.S. healthcare that still rely on manual calls between payors, providers and pharmacies; early traction included rapid provider adoption (tens of thousands of providers by 2021) and venture backing from notable firms such as GV, Coatue, and Kleiner Perkins[1].[1]
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Infinitus is positioned to expand as healthcare organizations prioritize reducing administrative burden and as voice AI models improve; near-term growth vectors include deeper EHR and CRM embedding, scaling enterprise features (like FastTrack), and expanding into adjacent administrative workflows across payors and pharma programs[2][5]. Continued success will depend on maintaining high accuracy and compliance, proving ROI at scale, and broadening partnerships that place agents directly in clinician and reimbursement workflows[4][3]. If Infinitus sustains its technical and regulatory rigor while scaling integrations, it could become a standard platform for automating phone‑based healthcare operations—effectively making a previously manual layer of healthcare communication far more efficient[5][2].